United States· US:0338-0221_888f2003-1dc2-4bc0-9b3b-ebe3948b9328

Plasma-Lyte A

A medicinal product containing magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate, registered in United States by Baxter Healthcare Corporation.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedPlasma-Lyte AATC—REGISTER NO.US:0338-0221_888f2003…PACKS LISTED4CHECKEDJuly 19, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
Manufacturer
Baxter Healthcare Corporation
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
July 19, 2026

Packs & prices · 4

  • ndc11
    0338022103
    500 mL in 1 BAG (0338-0221-03)
  • ndc11
    0338022104
    1000 mL in 1 BAG (0338-0221-04)
  • ndc11
    0338-0221-03
  • ndc11
    0338-0221-04

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Elonorm, Plasmalyt
  • Belgium · Ionolyte, Plasmalyte A Viaflo
  • Bulgaria · Плазма-Лайт 148 (Ph 7,4)
  • Cyprus · Ionolyte, Plasma-Lyte 148
  • Czechia · Isolyte, Plasmalyte
  • Denmark · Plasmalyte
  • Spain · Ionolyte, Viaflo Plasmalyte 148 (Ph 7,4)
  • Finland · Plasmalyte
  • France · Ionoven, Plasmalyte Viaflo
  • United Kingdom (Northern Ireland) · Ionolyte, Plasma-Lyte 148
  • Greece · Ionolyte, Plasma-Lyte 148 (Ph 7,4)
  • Croatia · Ionolyte, Plasma-Lyte 148 (Ph 7,4) Viaflo
  • Hungary · Isolyte
  • Ireland · Ionolyte, Plasma-Lyte 148 (Ph 7.4)
  • Iceland · Plasmalyte
  • Italy · Crystalsol, Elettrolitica Di Reintegrazione Con Sodio Gluconato
  • Lithuania · Plasmalyte
  • Luxembourg · Plasmalyte A Viaflo
  • Malta · Ionolyte, Plasma-Lyte 148 (Ph 7.4)
  • Netherlands · Ionolyte, Plasma-Lyte 148
  • Norway · Plasmalyte
  • Poland · Plasmalyte, Venolyte
  • Portugal · Ionolyte, Plasma-Lyte 148, Viaflo
  • Romania · Ionolyte, Plasmalyte
  • Sweden · Plasmalyte
  • Slovenia · Ionolyte, Plaslyte
  • Slovakia · Isolyte, Plasmalyte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd80a0c0-9f5a-461b-b0ef-1fba9a0908ea
GET /v1/drugs/cd80a0c0-9f5a-461b-b0ef-1fba9a0908ea?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "30; 37; 368; 526; 502",
  "substance": "MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE",
  "productndc": "0338-0221",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL",
  "application_number": "NDA017378",
  "marketing_category": "NDA"
}

See everything about magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.